Premium
P3‐040: VERUBECESTAT PHARMACOKINETIC AND EXPOSURE‐RESPONSE RESULTS FROM APECS, A PHASE 3 TRIAL IN PRODROMAL ALZHEIMER'S DISEASE
Author(s) -
Stone Julie A.,
Kleijn Huub Jan,
Jaworowicz David J.,
Passarell Julie,
Dockendorf Marissa,
Xu Ming,
Rasmussen Christian,
Humphrey Rebecca,
Voss Tiffini,
Egan Michael F.
Publication year - 2019
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2019.06.3066
Subject(s) - biomarker , cmax , medicine , placebo , pharmacokinetics , logistic regression , population , incidence (geometry) , adverse effect , area under the curve , oncology , pathology , chemistry , biochemistry , alternative medicine , environmental health , physics , optics